Amphotericin B-impregnated bone cement to treat refractory coccidioidal osteomyelitis

Research output: Contribution to journalArticle

5 Scopus citations


Use of amphotericin B-impregnated bone cement in combination with systemic antifungals for the treatment of coccidioidal osteomyelitis offers the potential for sustained local concentrations of drug at the site of the infection. Amphotericin B levels in bone of up to 5.1 μg/g have been demonstrated 4 months after placement of bone cement.

Original languageEnglish (US)
Pages (from-to)6341-6343
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Issue number12
StatePublished - Dec 2013


ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this